Growth Metrics

Oric Pharmaceuticals (ORIC) Amortizatization of Intangibles (2020 - 2026)

Oric Pharmaceuticals filings provide 7 years of Amortizatization of Intangibles readings, the most recent being -$162000.0 for Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 118.37% to -$162000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Mar 2026, down 81.41% year-over-year, with the annual reading at $2.3 million for FY2025, 71.62% down from the prior year.
  • Amortizatization of Intangibles hit -$162000.0 in Q1 2026 for Oric Pharmaceuticals, down from $240000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.3 million in Q2 2024 and bottomed at -$162000.0 in Q1 2026.
  • Average Amortizatization of Intangibles over 5 years is $1.0 million, with a median of $861000.0 recorded in 2023.
  • The largest annual shift saw Amortizatization of Intangibles skyrocketed 2150.0% in 2023 before it crashed 118.37% in 2026.
  • Oric Pharmaceuticals' Amortizatization of Intangibles stood at $620000.0 in 2022, then soared by 242.42% to $2.1 million in 2023, then dropped by 23.03% to $1.6 million in 2024, then tumbled by 85.31% to $240000.0 in 2025, then plummeted by 167.5% to -$162000.0 in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Amortizatization of Intangibles are -$162000.0 (Q1 2026), $240000.0 (Q4 2025), and $587000.0 (Q3 2025).